Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

37,319 public trials 4,954 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Recruiting

The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)

NCT07671924

Conditions
Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
Locations
  • BLC Clinical Research Burlington, Canada
  • Diex Recherche - Quebec Québec, Canada
  • Clinique Specialisee En Allergie De La Capitale Québec, Canada
  • Centre D'Investigation Clinique Mauricie Inc (CIC Mauricie) Trois-Rivières, Canada
View Trial Details
Recruiting

An External Control Arm Study in Non-Small Cell Lung Cancer

NCT07174388

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • Bayhealth Medical Center, Kent Campus Dover, Delaware, United States
  • Bayhealth Medical Center- Sussex Campus Milford, Delaware, United States
  • Northwest Oncology and Hematology Barrington, Illinois, United States
View Trial Details
Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

NCT07175038

Conditions
Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • University of California Davis Health Rancho Cordova, California, United States
  • University of Colorado Aurora, Colorado, United States
  • George Washington University Medical Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

NCT07705334

Conditions
Adenoma, Advanced or Metastatic Solid Tumors, Breast Diseases, +40 more
Locations
  • SCRI at HCA HealthONE Denver, Colorado, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
View Trial Details

Related conditions